Biotech | May 27, 2022
CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
First diagnostic centre to open in Mohali on August 31
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
Price band in the range of Rs 933 to Rs 954
Subscribe To Our Newsletter & Stay Updated
